School of Chinese Medicine, China Medical University, Taichung, Taiwan.
Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan.
PLoS One. 2021 May 7;16(5):e0250440. doi: 10.1371/journal.pone.0250440. eCollection 2021.
This study aimed to investigate the risk of Alzheimer's disease among patients with age-related macular degeneration and its association with confounding comorbidities.
This was a population-based, retrospective cohort study. By accessing data from the National Health Insurance Research Database of Taiwan, we identified 10,578 patients aged 50-100 years who were newly diagnosed with age-related macular degeneration between 2000 and 2012 and 10,578 non- age-related macular degeneration individuals. The comorbidities assessed were osteoporosis, diabetes, cirrhosis, cerebrovascular disease, chronic kidney disease, hypertension, hyperlipidemia, coronary artery disease, and chronic obstructive pulmonary disease.
Patients with age-related macular degeneration had a 1.23-fold increased risk of their condition advancing to Alzheimer's disease (aHR = 1.23, 95% CI = 1.04-1.46). The younger patients were diagnosed with age-related macular degeneration, the more likely patients got Alzheimer's disease (50-64 age group: aHR = 1.97, 95% CI = 1.04-3.73; 65-79 age group: aHR = 1.27, 95% CI = 1.02-1.58; 80-100 age group: aHR = 1.06, 95% CI = 0.78-1.45). In addition, there were significantly higher risks of Alzheimer's disease for patients with cirrhosis (aHR = 1.50, 95% CI = 1.09-2.06) in the age-related macular degeneration cohort than in the non-age-related macular degeneration cohort.
Patients with age-related macular degeneration may exhibit a higher risk of Alzheimer's disease than people without age-related macular degeneration.
本研究旨在探讨年龄相关性黄斑变性患者罹患阿尔茨海默病的风险及其与混杂合并症的关系。
这是一项基于人群的回顾性队列研究。通过访问来自台湾全民健康保险研究数据库的数据,我们确定了 10578 名年龄在 50-100 岁之间的患者,他们在 2000 年至 2012 年间被新诊断为年龄相关性黄斑变性,同时还有 10578 名非年龄相关性黄斑变性患者作为对照。评估的合并症包括骨质疏松症、糖尿病、肝硬化、脑血管疾病、慢性肾脏病、高血压、高血脂、冠心病和慢性阻塞性肺疾病。
年龄相关性黄斑变性患者发展为阿尔茨海默病的风险增加了 1.23 倍(aHR = 1.23,95%CI = 1.04-1.46)。年龄相关性黄斑变性患者的年龄越小,发展为阿尔茨海默病的可能性越大(50-64 岁年龄组:aHR = 1.97,95%CI = 1.04-3.73;65-79 岁年龄组:aHR = 1.27,95%CI = 1.02-1.58;80-100 岁年龄组:aHR = 1.06,95%CI = 0.78-1.45)。此外,年龄相关性黄斑变性患者中肝硬化(aHR = 1.50,95%CI = 1.09-2.06)的阿尔茨海默病风险明显高于非年龄相关性黄斑变性患者。
年龄相关性黄斑变性患者可能比没有年龄相关性黄斑变性的患者患阿尔茨海默病的风险更高。